Skip to main content
SpringerLink
Log in
Book cover

Achieving Respiratory Health Equality pp 131–138Cite as

Sickle Cell Disease

  • Chapter
  • First Online:

  • 624 Accesses

Part of the book series: Respiratory Medicine ((RM))

Abstract

Sickle cell disease is an illness that predominantly affects African Americans in the United States, where it is an important and under-recognized problem. In this country, research funding for sickle cell disease is substantially lower than that for other monogenic diseases such as cystic fibrosis. Such disparities in research funding lead to limited knowledge translation or therapeutic innovation, ultimately affecting the care of patients with sickle cell disease. Moreover, disparities in access to and quality of healthcare affect outcomes in sickle cell disease, including those for respiratory health. Several steps, including increased research funding from private foundations and government agencies, standardization and accreditation for the delivery of care, and other measures to reduce healthcare disparities (e.g., improved management of pain and co-existing asthma), should have substantial benefits for subjects with SCD, including prolonging and improving life while reducing healthcare costs.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Scott RB. Sickle-cell anemia—high prevalence and low priority. N Engl J Med. 1970;282(3):164–5. doi:10.1056/NEJM197001152820312.

    Article  CAS  PubMed  Google Scholar 

  2. McClish DK, Smith WR, Dahman BA, Levenson JL, Roberts JD, Penberthy LT, et al. Pain site frequency and location in sickle cell disease: the PiSCES project. Pain. 2009;145(1–2):246–51. doi:10.1016/j.pain.2009.06.029.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hassell K, Pace B, Wang W, Kulkarni R, Luban N, Johnson CS, et al. Sickle cell disease summit: from clinical and research disparity to action. Am J Hematol. 2009;84(1):39–45. doi:10.1002/ajh.21315.

    Article  PubMed  Google Scholar 

  4. Strouse JJ, Lobner K, Lanzkron S, Haywood C. NIH and National Foundation Expenditures for sickle cell disease and cystic fibrosis are associated with Pubmed publications and FDA approvals. Blood. 2013;122(21):1739.

    Google Scholar 

  5. Smith LA, Oyeku SO, Homer C, Zuckerman B. Sickle cell disease: a question of equity and quality. Pediatrics. 2006;117(5):1763–70. doi:10.1542/peds.2005-1611.

    Article  PubMed  Google Scholar 

  6. Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115(17):3447–52. doi:10.1182/blood-2009-07-233700.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood. 2004;103(11):4023–7. doi:10.1182/blood-2003-11-3758.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Serjeant GR. Treatment of sickle cell disease in early childhood in Jamaica. Am J Pediatr Hematol Oncol. 1985;7(3):235–9.

    Article  CAS  PubMed  Google Scholar 

  9. Woods K, Karrison T, Koshy M, Patel A, Friedmann P, Cassel C. Hospital utilization patterns and costs for adult sickle cell patients in Illinois. Public Health Rep. 1997;112(1):44–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Raphael JL, Dietrich CL, Whitmire D, Mahoney DH, Mueller BU, Giardino AP. Healthcare utilization and expenditures for low income children with sickle cell disease. Pediatr Blood Cancer. 2009;52(2):263–7. doi:10.1002/pbc.21781.

    Article  PubMed  Google Scholar 

  11. Carroll CP, Haywood Jr C, Fagan P, Lanzkron S. The course and correlates of high hospital utilization in sickle cell disease: evidence from a large, urban Medicaid managed care organization. Am J Hematol. 2009;84(10):666–70. doi:10.1002/ajh.21515.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Lanzkron S, Carroll CP, Haywood Jr C. The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database. Am J Hematol. 2010;85(10):797–9. doi:10.1002/ajh.21807.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Laurence B, Haywood Jr C, Lanzkron S. Dental infections increase the likelihood of hospital admissions among adult patients with sickle cell disease. Community Dent Health. 2013;30(3):168–72.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Aisiku IP, Penberthy LT, Smith WR, Bovbjerg VE, McClish DK, Levenson JL, et al. Patient satisfaction in specialized versus nonspecialized adult sickle cell care centers: the PiSCES study. J Natl Med Assoc. 2007;99(8):886–90.

    PubMed  PubMed Central  Google Scholar 

  15. Porter J, Feinglass J, Artz N, Hafner J, Tanabe P. Sickle cell disease patients’ perceptions of emergency department pain management. J Natl Med Assoc. 2012;104(9–10):449–54.

    Article  PubMed  Google Scholar 

  16. Haywood Jr C, Lanzkron S, Ratanawongsa N, Bediako SM, Lattimer-Nelson L, Beach MC. Hospital self-discharge among adults with sickle-cell disease (SCD): associations with trust and interpersonal experiences with care. J Hosp Med. 2010;5(5):289–94. doi:10.1002/jhm.643.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Haywood Jr C, Lanzkron S, Ratanawongsa N, Bediako SM, Lattimer L, Powe NR, et al. The association of provider communication with trust among adults with sickle cell disease. J Gen Intern Med. 2010;25(6):543–8. doi:10.1007/s11606-009-1247-7.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Elander J, Beach MC, Haywood Jr C. Respect, trust, and the management of sickle cell disease pain in hospital: comparative analysis of concern-raising behaviors, preliminary model, and agenda for international collaborative research to inform practice. Ethn Health. 2011;16(4–5):405–21. doi:10.1080/13557858.2011.555520.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Bediako SM, Lanzkron S, Diener-West M, Onojobi G, Beach MC, Haywood Jr C. The measure of sickle cell stigma: initial findings from the improving patient outcomes through respect and trust study. J Health Psychol. 2014;21:808–20. doi:10.1177/1359105314539530.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Haywood Jr C, Williams-Reade J, Rushton C, Beach MC, Geller G. Improving clinician attitudes of respect and trust for persons with sickle cell disease. Hosp Pediatr. 2015;5(7):377–84. doi:10.1542/hpeds.2014-0171.

    Article  PubMed  Google Scholar 

  21. Lazio MP, Costello HH, Courtney DM, Martinovich Z, Myers R, Zosel A, et al. A comparison of analgesic management for emergency department patients with sickle cell disease and renal colic. Clin J Pain. 2010;26(3):199–205. doi:10.1097/AJP.0b013e3181bed10c.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Pritchard KA, Feroah TR, Nandedkar SD, Holzhauer SL, Hutchins W, Schulte ML, et al. Effects of experimental asthma on inflammation and lung mechanics in sickle cell mice. Am J Respir Cell Mol Biol. 2011;46:389–96. doi:10.1165/rcmb.2011-0097OC.

    Article  PubMed  Google Scholar 

  23. Leong MA, Dampier C, Varlotta L, Allen JL. Airway hyperreactivity in children with sickle cell disease. J Pediatr. 1997;131(2):278–83.

    Article  CAS  PubMed  Google Scholar 

  24. Koumbourlis AC, Zar HJ, Hurlet-Jensen A, Goldberg MR. Prevalence and reversibility of lower airway obstruction in children with sickle cell disease. J Pediatr. 2001;138(2):188–92. doi:10.1067/mpd.2001.111824.

    Article  CAS  PubMed  Google Scholar 

  25. Vendramini EC, Vianna EO, De Lucena AI, De Castro FB, Martinez JA, Terra-Filho J. Lung function and airway hyperresponsiveness in adult patients with sickle cell disease. Am J Med Sci. 2006;332(2):68–72.

    Article  PubMed  Google Scholar 

  26. Sylvester KP, Patey RA, Rafferty GF, Rees D, Thein SL, Greenough A. Airway hyperresponsiveness and acute chest syndrome in children with sickle cell anemia. Pediatr Pulmonol. 2007;42(3):272–6. doi:10.1002/ppul.20571.

    Article  PubMed  Google Scholar 

  27. Ozbek OY, Malbora B, Sen N, Yazici AC, Ozyurek E, Ozbek N. Airway hyperreactivity detected by methacholine challenge in children with sickle cell disease. Pediatr Pulmonol. 2007;42(12):1187–92. doi:10.1002/ppul.20716.

    Article  PubMed  Google Scholar 

  28. Boyd JH, Macklin EA, Strunk RC, DeBaun MR. Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood. 2006;108(9):2923–7. doi:10.1182/blood-2006-01-011072.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Boyd JH, Macklin EA, Strunk RC, DeBaun MR. Asthma is associated with increased mortality in individuals with sickle cell anemia. Haematologica. 2007;92(8):1115–8.

    Article  PubMed  Google Scholar 

  30. Glassberg J, Spivey JF, Strunk R, Boslaugh S, DeBaun MR. Painful episodes in children with sickle cell disease and asthma are temporally associated with respiratory symptoms. J Pediatr Hematol Oncol. 2006;28(8):481–5. doi:10.1097/01.mph.0000212968.98501.2b.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Glassberg JA, Chow A, Wisnivesky J, Hoffman R, Debaun MR, Richardson LD. Wheezing and asthma are independent risk factors for increased sickle cell disease morbidity. Br J Haematol. 2012;159:472–9. doi:10.1111/bjh.12049.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Glassberg JA, Wang J, Cohen R, Richardson LD, DeBaun MR. Risk factors for increased ED utilization in a multinational cohort of children with sickle cell disease. Acad Emerg Med. 2012;19(6):664–72. doi:10.1111/j.1553-2712.2012.01364.x.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Jeffrey Glassberg MD

  2. Department of Medicine and Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA

    Michael R. DeBaun MD, MPH

Authors
  1. Jeffrey Glassberg MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael R. DeBaun MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael R. DeBaun MD, MPH .

Editor information

Editors and Affiliations

  1. Division of Pediatric Pulmonary Medicine, Allergy, and Immunology, Children’s Hospital of Pittsburgh of UPMC, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    Juan Carlos Celedón

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Glassberg, J., DeBaun, M.R. (2017). Sickle Cell Disease. In: Celedón, J. (eds) Achieving Respiratory Health Equality. Respiratory Medicine. Humana Press, Cham. https://doi.org/10.1007/978-3-319-43447-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43447-6_11

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-43445-2

  • Online ISBN: 978-3-319-43447-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation